Woman suffers ‘life-threatening bowel injury’ from Ozempic: suit

health

by andrew coat

Ozempic users will suffer from diarrhea for the rest of their lives after sustaining severe intestinal damage caused by injections of the popular weight loss drug.

The unidentified woman is one of more than a dozen people who have filed a lawsuit against Novo Nordisk, the parent company of Ozempic and sister drug Wigovy, since November, according to a report released Saturday. Daily Mail.

All plaintiffs claimed the jab caused gastroparesis, a rare condition that affects the spontaneous movement of the stomach muscles.

Gastroparesis leaves patients with nausea, bloating, and severe abdominal pain. mayo clinic. It can also cause vomiting, weight loss, and malnutrition.

The woman was diagnosed with “life-threatening intestinal damage” after using Ozempic, and surgeons subsequently performed an eight-hour surgery in hopes of repairing her colon, according to the lawsuit.

Although she managed to survive the terrifying medical episode, doctors reportedly told her she would be in pain “for the rest of her life” and would “never have a proper bowel movement again.”

The woman is now accusing Novo Nordisk of “failing to properly warn about the risk of gastroparesis on the drug's packaging.”

It is unclear whether she was using the drug for weight loss or to treat diabetes. It is also unclear how long she had been using the drug before her intestinal damage.

Both Ozempic and Wegovy were originally designed for patients with type 2 diabetes and were subsequently prescribed by doctors to help patients lose weight.

Semaglutide is a drug that is injected once a week into the stomach, thigh, or arm. When blood sugar levels are high, the pancreas releases appropriate amounts of insulin.

“Semaglutide is produced during meals. It tells the brain that we are full,” Dr. Katherine H. Sanders, a New York City internist, previously told the Post.

“It helps people feel less hungry, feel full sooner, and stay fuller longer, but also when they actually feel full. few full. “

The jab has helped thousands of users slim down quickly, but in a separate lawsuit obtained by the Daily Mail, one Wegovy user claims he didn't have a bowel movement for a week.

The plaintiff was rushed to the hospital, where doctors diagnosed gastroparesis.

The Post has reached out to Novo Nordisk for comment on the multiple lawsuits.

Meanwhile, weight loss drugs made by other major pharmaceutical companies are said to cause similar problems.

The third lawsuit seen by the Daily Mail is said to have been filed against Eli Lilly, the maker of Mounjaro, another injectable drug that works similarly to Wegovy and Ozempic.

According to legal documents, a woman who used both Ozempic and Munjaro was “diagnosed with gastroparesis and vomited to the point that some of her teeth fell out.”

At least nine other lawsuits have been filed against Eli Lilly, according to the report.

Florida attorney Cameron Stephenson told the Daily Mail that his office “currently has approximately 100 clients who have been diagnosed with gastroparesis” after using injectable drugs. He believes current suits are just the tip of the iceberg.

“There is no doubt in my mind that there will be thousands of cases,” he declared.

Blair Hand, a 23-year-old mother of two, is one of the Ozempic users who filed a lawsuit against Novo Nordisk.

She said she developed gastroparesis after being prescribed Ozempic to lose weight and treat pre-diabetes in May last year.

The Oklahoma native reportedly suffered from nausea, vomiting and constipation before being admitted to intensive care during her fifth hospital visit.

“My body is so acidic that if I had waited another day, I wouldn't have survived,” Hand declared in his suit. “It was scary. It hurt. I've never experienced pain like that in my life and I don't want to experience it again.”

She called on drug companies to be more transparent about the potential side effects of the super popular drug.

“I think they should definitely advertise more about the risks it carries,” she wrote.